MECP2 and respiratory tract infectious disorder: Altered levels of MeCP2 either through loss-of-function mutations (Rett Syndrome (RTT)) or increased protein levels due to gene duplication or triplication (MeCP2 Duplication Syndrome) (Amir et al., 1999; Ramocki et al., 2010), results in dramatic phenotypes including mild to profound intellectual disabilities, motor dysfunction, features of autism, stereotyped hand movements, recurrent respiratory infections, and sleep disturbances, and are known collectively as MeCP2 spectrum disorders (MSD).